December 23, 2023

Comparing the Long-Term Effectiveness of Infliximab and Adalimumab for Psoriasis

Based on Kaplan–Meier analysis, the survival time for infliximab is comparatively longer than that for adalimumab; however, there are no significant differences between the two drugs based on retention rate, with their efficacy diminishing over time. Psoriasis can be described as a chronic immune-mediated disorder that requires lifelong treatment. A drug’s survival and retention rates...

Laser Therapy, Microneedling, and Chemical Peels for Skin of Color

As the aesthetics industry continues to grow, clinicians must educate themselves regarding appropriate treatments and protocols for patients with skin of color to prevent adverse reactions. There is a lack of information for Fitzpatrick skin types IV–VI, and increasing knowledge and skills is imperative for safe and effective treatments. With exponential growth in the aesthetics...

Stay informed on the latest health disparities research, cultural sensitivity education, and how you can help improve patient outcomes.
This field is for validation purposes and should be left unchanged.